The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Michel Azizi

Université Paris Descartes

Faculté de Médecine

Paris

France

[email]@egp.ap-hop-paris.fr

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Université Paris Descartes, Faculté de Médecine, Paris, France. 2007
  • Centre d'Investigations Cliniques, Assistance Publique des Hôpitaux de Paris AP-HP et INSERM, Hôpital Européen Georges Pompidou, France. 2000 - 2005
  • Centre d'Investigations Cliniques, Hôpital Européen Georges Pompidou, 20-40 rue Leblanc, 75908 Paris cedex 15, France. 2003

References

  1. Hormonal and hemodynamic effects of aliskiren and valsartan and their combination in sodium-replete normotensive individuals. Azizi, M., Ménard, J., Bissery, A., Guyene, T.T., Bura-Rivière, A. Clin. J. Am. Soc. Nephrol (2007) [Pubmed]
  2. Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans. Azizi, M., Boutouyrie, P., Bissery, A., Agharazii, M., Verbeke, F., Stern, N., Bura-Rivière, A., Laurent, S., Alhenc-Gelas, F., Jeunemaitre, X. J. Clin. Invest. (2005) [Pubmed]
  3. Integrating drug pharmacokinetics for phenotyping individual renin response to angiotensin II blockade in humans. Azizi, M., Bissery, A., Lamarre-Cliche, M., Ménard, J. Hypertension (2004) [Pubmed]
  4. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Azizi, M., Ménard, J. Circulation (2004) [Pubmed]
  5. Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption. Azizi, M., Ménard, J., Bissery, A., Guyenne, T.T., Bura-Rivière, A., Vaidyanathan, S., Camisasca, R.P. J. Am. Soc. Nephrol. (2004) [Pubmed]
  6. Dual renin-angiotensin system blockade restores blood pressure-renin dependency in individuals with low renin concentrations. Azizi, M., Bissery, A., Bura-Rivière, A., Ménard, J. J. Hypertens. (2003) [Pubmed]
  7. Functional consequences of angiotensin-converting enzyme gene polymorphism on N-acetyl-Ser-Asp-Lys-Pro degradation and angiotensin II production. Azizi, M., Junot, C., Ezan, E., Hallouin, M.C., Guyene, T., Ménard, J. J. Mol. Med. (2002) [Pubmed]
  8. Angiotensin I-converting enzyme and metabolism of the haematological peptide N-acetyl-seryl-aspartyl-lysyl-proline. Azizi, M., Junot, C., Ezan, E., Ménard, J. Clin. Exp. Pharmacol. Physiol. (2001) [Pubmed]
  9. Influence of the M235T polymorphism of human angiotensinogen (AGT) on plasma AGT and renin concentrations after ethinylestradiol administration. Azizi, M., Hallouin, M.C., Jeunemaitre, X., Guyene, T.T., Ménard, J. J. Clin. Endocrinol. Metab. (2000) [Pubmed]
 
WikiGenes - Universities